If decreased systemic activity of the kallikrein system, is associated with development of diabetic nephropathy and associated complications, diminished serum kininogen-1 identified in our study may be an early marker of kidney function deterioration in pregnant women with T1DM not yet seen in routine urinalysis. Here, KLK4 is linked to diabetic kidney disease.